Samsung Bioepis has allegedly sub-licensed its Stelara biosimilar rights to a health conglomerate, breaching a previous ...

Johnson & Johnson sued Samsung Bioepis for allegedly breaching a contract agreement over its launch of a biosimilar to ...

Samsung Bioepis allegedly entered into an agreement with a third-party health company, allowing it to market its own private ...

It was also the year that Samsung chose to quietly enter India, setting up its first office in Delhi with just two employees.

As biosimilar versions of a big-selling Johnson & Johnson medicine reach the U.S. market, the health care giant accused one ...

Samsung's Galaxy S25 series offers a bunch of customization features, but can you tweak the vibration intensity on any of the ...

Samsung rolled out the Android 10-based One UI 2.0 beta update for the Galaxy Note10 and Galaxy Note10+ in a few countries ...

Apple on Wednesday announced a cheaper new version of the iPhone 16 called the iPhone 16e, signaling a renewed push into the ...